Chemical Structure (Amlodipine 01)
Amlodipine And Atorvastatin Tablet, Coated
Product Images NDC 66993-272
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 66993-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Amlodipine 02)
Figure 1 (Amlodipine 03)
This is a graph displaying event rates and a survival analysis of a drug called Amlodipine. The graph shows the event rate decreasing over time, with a P-value of 0.003 and a Hazard Ratio of 0.691, suggesting that Amlodipine is effective in reducing events. The 95% CI is between 0.54 and 0.88. The table below the graph shows the number of individuals at risk over time.*
Figure 2 (Amlodipine 04)
This is a table presenting data from a study comparing the effects of Amlodipine and Placebo in patients with single or multiple diseases. The patients were divided based on their age, gender, the number of vessels with stenosis, and PCI-stent strategies. The table provides information on the mean sitting baseline SBP, which was found to be 120 mmHg.*
Figure 3 (Amlodipine 05)
Figure 4 (Amlodipine 06)
The text contains a graph for cumulative hazards (%) of Placebo and Atorvastatin for Time to First Primary Endpoint Through Four (4) Years of Follow-up (Years). Atorvastatin showed a significant decrease in hazard compared to placebo with HR 0.63 (0.48-0.83) p=0.001.*
Figure 5 (Amlodipine 07)
The text describes the percentage of subjects who experienced a major cardiovascular endpoint while taking either atorvastatin 10 mg or atorvastatin 80 mg. The data shows a lower incidence of such events in the group taking atorvastatin 80 mg compared to those taking the lower dose. Time to the first major cardiovascular endpoint is also graphically represented over a period of four years.*
Principal Display Panel (2.5 mg/10 mg Tablet Bottle Label)
This is a description of a medication bottle containing 30 tablets of Amlodipine and Atorvastatin. The recommended storage temperature is between 15-30°C (53-86°F). Each tablet contains 2.5 mg of Amlodipine and 10.4 mg of Atorvastatin. The medication is manufactured in Germany and distributed in the USA by an Ohio-based company. The bottle has a Data Matrix area and a color-free area along with a regulatory text area. Additional information can be found in the prescribing information which is included with the medication.*
Principal Display Panel (2.5 mg/20 mg Tablet Bottle Label)
This is a description of a medication called Amlodipine and Atorvastatin, containing 30 tablets, with a total equivalent of 3.47 mg amlodipine and 20.7 mg atorvastatin calcium. The medication should be stored at a temperature range of 15 to 30°C (53 to 86°F), but can be stored briefly at 25°C (77°F). The manufacturer is Prasco Laboratories located in Mason, OH, USA and the product was made in Germany.*
Principal Display Panel (2.5 mg/40 mg Tablet Bottle Label)
This text provides information about a medication named Amlodipine and Mtorvastatin. It comes in the form of tablets where each contains 2.5mg amlodipine and 40mg atorvastatin. The medication is distributed by Prasco Laboratories, and the recommended storage temperature for the tablets is between 15-30°C (53-86°F). The NDC number is 6693-265-30 and GTIN is not mentioned.*
Principal Display Panel (5 mg/10 mg Tablet Bottle Label)
This text appears to be a medication package insert. It provides storage instructions for Amlodipine and Atorvastatin tablets, and dosage and use recommendations. It also lists the ingredients and quantities of each tablet. The medication is produced by Prasco Laboratories based in Ohio, USA and made in Germany.*
Principal Display Panel (5 mg/20 mg Tablet Bottle Label)
This is a prescription medication called Amlodipine and Atorvastatin Tablets, containing 5mg amlodipine and 20mg atorvastatin. It is distributed by Prasco Laboratories in Mason, Ohio, and made in Germany. The medication should be stored at a temperature between 15-30°C (53-86°F) and each bottle comes with 30 tablets. The prescribing information should be consulted for proper usage guidelines. *
Principal Display Panel (5 mg/40 mg Tablet Bottle Label)
This is a medication package containing 30 tablets of Amlodipine and Atorvastatin, each tablet is equivalent to 5mg Amlodipine and 40mg Atorvastatin. The tablets should be stored at room temperature not exceeding 30°C (86°F) and not lower than 15°C (53°F). The controlling entity for this medication is USP Controlled A PRASCO. The medication is distributed by Prasco Laboratories located in Mason, OH, USA.*
Principal Display Panel (5 mg/80 mg Tablet Bottle Label)
Store the Amlodipine and Atorvastatin Tablets at a temperature range of 15-30°C (53-86°F), with excursions permitted to 25°C (77°F) as per the USP Controlled Room Temperature guidelines. Each tablet contains 5 mg amlodipine and 80 mg atorvastatin, distributed by Prasco Laboratories in the United States. For information on dosage and usage, please refer to the prescribing information provided. The product is manufactured in Germany and comes in a package of 30 tablets with the NDC code of 66993-269-30. This medication is only available with a prescription.*
Principal Display Panel (10 mg/10 mg Tablet Bottle Label)
This is a medication containing Amlodipine and Atorvastatin in tablet form with 30 tablets per container. The recommended storage temperature is between 15-30°C (53-86°F) and can be stored at room temperature. The medication is produced in Germany and distributed by PRASCO. The dosage strength of each tablet is 13.9mg of amlodipine besylate and 10mg of atorvastatin. The product's NDC number is 6693-270-30 and the GTIN number is 366993270302. The information on the label is approved by the United States Pharmacopeia (USP).*
Principal Display Panel (10 mg/20 mg Tablet Bottle Label)
This is a description of a medication. It contains a total of 30 tablets (10mg Amlodipine/20mg Atorvastatin). The medication should be stored at a temperature between 15-30°C (53-86°F), and it's allowed to be stored at 25°C (77°F). The accompanying prescribing information should be consulted before taking. It was manufactured in Germany and distributed by an American company located in Mason, OH.*
Principal Display Panel (10 mg/40 mg Tablet Bottle Label)
This is a description of a medication distributed by Prasco Laboratories called Amlodipine and Atorvastatin in the form of 30 tablets with a strength of 10 mg/40 mg. It should be stored at a temperature between 15-30°C (53-86°F). The medication is made in Germany and may have a lot number printed on the packaging.*
Principal Display Panel (10 mg/80 mg Tablet Bottle Label)
This medication contains 10mg of amlodipine and 80mg of atorvastatin in each tablet, and should be stored at room temperature not exceeding 25°C (77°F) with excursions allowed to 15-30°C (53-86°F). The tablets come in a pack containing 30 tablets and are manufactured in Germany. NDC reference number is 6693-273-30, and UPC code is PRASCO 00366993273303.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
